Before reading the job post, we encourage you to watch this video about our company. It gives you an inside look at how we started, the team and culture that made us successful, and where we're going. It's easy to read a job post and apply, but people often wonder about the culture and whether they would fit in. If you want to call Harrow your home and genuinely want to be part of a family and something big, then we encourage you to click this link and get to know us.
Who is Harrow?
Harrow (Nasdaq: HROW) is a leading U.S. ophthalmic-focused pharmaceutical company. The Company was founded and continues operating based on the highest corporate values. Members of our Harrow Family often express their pride in being a part of our commitment to (1) innovation, (2) patient access to and affordability of our medicines, and (3) our track record of having never turned down an ophthalmologist doing mission work around the world – providing free medicines in support of mission work aimed at giving or maintaining the gift of sight to those most in need.
At Harrow, we foster our individual and collective entrepreneurial and creative spirits. We focus on pursuing opportunities for drug candidates in underserved markets. We are data-driven and use our access to real-world clinical experience to lower the investment risks of our work. We concentrate on the commercial appeal of high-value assets, and our objective is to seek to make paradigm-shifting medicines available to patients as soon as possible. Our approach to finding high-value opportunities and balancing risk with real-world experience can deliver exceptional value for all our stakeholders.
Harrow’s ophthalmic pharmaceutical portfolio is one of the most comprehensive in the industry, including:
- IHEEZO:
- A broad Dry Eye Disease product line, led by VEVYE® and bolstered by well-known adjacent ocular surface disease products such as FLAREX® and TOBRADEX® ST;
- TRIESENCE®:
- A Specialty Anterior Segment product line, which includes various high-need and utility products such as ILEVRO®, NEVANAC®, and VERKAZIA®;
- ImprimisRx is the nation’s leading ophthalmology-focused compound pharmacy, including an FDA-registered and FDA-inspected 503B outsourcing facility and a 50-state mail-order pharmacy. The division of Harrow serves as an innovation hub and plays a vital role in Harrow’s mission to help patients maintain their gift of sight.
Job Summary
The Business Engagement Manager will be responsible for managing business in an assigned base of new and existing customers for Ophthalmology and Retina. This position will report to the VP of Posterior Portfolio and will participate as a key member of the commercial team within their assigned region with primary responsibilities that includes obtaining various MBO’s inclusive of managing current GPO contracts and having quarterly business reviews with accounts in assigned geography. The role will also include customer retention and advocacy that ensures portfolio performance achieves defined outcomes. This role will also cultivate executive leadership relationships in assigned accounts. This individual will be ideally based in a location with relatively easy access to the base of assigned customers. The position requires travel up to 50% of the time.
Core Responsibilities
- Primary responsibility is to appropriately communicate, educate, and explain to practices/ASC’s and said leadership the posterior portfolio GPO contract offerings, and any updates on such offerings, using approved messaging and materials.
- The BEM play an account management role by serving as a liaison between Harrow and their assigned accounts as identified by commercial leadership.
- Appropriate utilization of the Customer Relationship Management (CRM) system.
- Execute cohesive strategies and collaborate compliantly with Marketing, Field sales, GPO, Market Access and Inside Sales.
- Effectively manage assigned operating expense budget for travel and customer training.
- Monitor Harrow share % of portfolio products within assigned territory or accounts.
- Evaluate customer, market and competitor activity and update the organization accordingly.
- Establish and maintain effective access and reimbursement initiatives and triage where appropriate.
- Utilize resources to enhance productivity and provide optimal customer satisfaction.
- Requires a high level of communication and collaboration with the Area Sales Director and KAM Team on strategic initiatives and physician engagement.
Qualifications & Requirements
- 5-10+ years of strategic Retina and/or Ophthalmology sales experience, ophthalmic market preferred specific to Ophthalmology and Retina.
- Bachelor’s degree with MBA desirable (additional years of service can replace MBA)
- Experience with execution of targeted business plans around priorities and goals.
- C Suite Business Acumen for executive presentation, engagement and appropriate follow up.
- Team player with a positive, can-do attitude
- Strong written, verbal and presentation communication skills including executive preparation and delivery of C Suite presentations.
- Ability to think creatively in confronting issues and pursuing novel approaches to old problems.
- Ability to work under pressure, meet deadlines and exercise sound business judgment with critical thinking skills and high ethical standards.
- Ability to manage multiple projects simultaneously, adjusting priorities as needed and meeting deadlines
- Proficient in the use of CRMs and Microsoft Office software products.
Position Type
- Remote
Travel
- Up to 50% including overnight stays.
What We Do
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market.
Our mission as a growing leader in the ophthalmic healthcare market is driven by two core values: (1) unyielding dedication to innovation and (2) a mission of providing affordable and accessible medications. We pride ourselves on closely listening to the needs of providers and their patients, so we can do everything in our power to address them with high-quality products and services.
Our worthwhile mission is producing amazing financial results, and because we’ve produced a 72% compound annual growth rate for our first eight years in business, we are one of the fastest-growing ophthalmic pharmaceutical companies in the United States.
